World News | Naomi Kresge, Robert Langreth and Riley Griffin, Bloomberg | Thursday December 9, 2021
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine may be needed to neutralize the omicron variant, results that will accelerate booster-shot drives around the world and may lead to use of new strain-spec
www.ndtv.com